Evidence map›Paper›PMID 37508276›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Diflunisal and Analogue Pharmacophores Mediating Suppression of Virulence Phenotypes in

Liana C Chan, Hong K Lee, Ling Wang, Siyang Chaili, Yan Q Xiong, Arnold S Bayer, Richard A Proctor, Michael R Yeaman

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Attenuation ofAntibiotics (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Repurposing Diflunisal as an Antivirulence Agent AgainstInfectious microbes & diseases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Liana C ChanDivision of Molecular Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.ORCID 0000-0003-2567-4418
Hong K LeeDivision of Molecular Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Ling WangDivision of Molecular Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Siyang ChailiVanderbilt Eye Institute, Vanderbilt University Medical Center, 2311 Pierce Ave., Nashville, TN 37232, USA.
Yan Q XiongDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
Arnold S BayerDivision of Infectious Diseases, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.ORCID 0000-0003-1968-0192
Richard A ProctorDepartments of Medical Microbiology & Immunology and Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
Michael R YeamanDivision of Molecular Medicine, Harbor-UCLA Medical Center, Torrance, CA 90502, USA.ORCID 0000-0002-9468-5252
University of California, Los Angeles · USUCLA Medical Center · USUniversity of Wisconsin–Madison · USVanderbilt University Medical Center · US

Funding

The Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1M
Systems Immunolobiology of Antibiotic-Persistent MRSA InfectionU01AI124319 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2020
$10.1M
Mitigating Resistance & Virulence in MRSAR33AI111661 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2018
$1.2M
Mitigating Resistance & Virulence in MRSAR21AI111661 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2014 to 2015
$378k
National Institute of Allergy and Infectious Diseases AI-111661-01National Institute of Allergy and Infectious Diseases U01-AI124319NCATS NIH HHS KL2 TR001882Southern California Clinical and Translational Science Institute KL2-TR001882-05
6 · The paper itself

Abstract

Invasive methicillin-resistant

Indexed as

analoguesantimicrobialdiflunisalpharmacophoreStaphylococcus aureusvirulence

Identifiers

PMID37508276
PMCPMC10376238
OpenAlexW4384203660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.